Peripheral vascular disease

Renal Guard System to Prevent Contrast Induced Acute Kidney Injury in Patients at High Risk Contrast Induced Acute Kidney Injury

Contrast Induced Acute Kidney Injury (CI-AKI) is associated to increased costs and unfavorable results after hemodynamic procedures....

solaci - 3 August, 2022

Learn More

Femoropopliteal

DISRUPT-PAD III: Followup of IVL Treatment in Femoropopliteal Territory

Femoropopliteal segment calcification can generate complications for both preparation and execution of endovascular therapies for patients with...

solaci - 3 August, 2022

Learn More

Antithrombotic Anticoagulants

Are Elevated Lipoprotein (a) Levels Associated with Increased Adverse Events After Peripheral Endovascular Treatment?

Peripheral arterial disease is a manifestation of systemic atherosclerotic disease with increasing prevalence. Moreover, this disease is...

solaci - 29 July, 2022

Learn More

Femoral

Thromboendarterectomy vs. Endovascular Therapy in Common Femoropopliteal Territory. Is Surgery Still the Gold Standard?

For lesions in the common femoral artery, guidelines recommend surgical endarterectomy (TEA) as the gold standard. However,...

solaci - 11 July, 2022

Learn More

Femoropopliteal

Intermittent Claudication: Invasive Treatment Superior to Pharmacological Treatment?

Peripheral vascular disease is strongly associated to cardiovascular events and a negative impact on health status and...

solaci - 7 July, 2022

Learn More

Other

Complicated Non-Stenotic Carotid Plaques: A Light in the Diagnosis of Cryptogenic Stroke?

Stroke is one of the leading causes of death and disability. It produces great morbidity by causing...

solaci - 27 June, 2022

Learn More

Femoropopliteal

IN.PACT Global: Follow Up of Real-Life Patient in Femoropopliteal Territory

Drug coated balloons (DCB) emerged as an innovative treatment approximately 10 years ago. Since then, numerous randomized...

solaci - 27 June, 2022

Learn More

Other

A Nod to Catheter-Guided Thrombolysis in Pulmonary Thromboembolism

Pulmonary thromboembolism (PTE) is the third most frequent cardiovascular disease, with an increasing prevalence over time. The...

solaci - 7 June, 2022

Learn More

Peripheral vascular disease

Renal Guard System to Prevent Contrast Induced Acute Kidney Injury in Patients at High Risk Contrast Induced Acute Kidney Injury

DISRUPT-PAD III: Followup of IVL Treatment in Femoropopliteal Territory

Are Elevated Lipoprotein (a) Levels Associated with Increased Adverse Events After Peripheral Endovascular Treatment?

Thromboendarterectomy vs. Endovascular Therapy in Common Femoropopliteal Territory. Is Surgery Still the Gold Standard?

Intermittent Claudication: Invasive Treatment Superior to Pharmacological Treatment?

Complicated Non-Stenotic Carotid Plaques: A Light in the Diagnosis of Cryptogenic Stroke?

IN.PACT Global: Follow Up of Real-Life Patient in Femoropopliteal Territory

A Nod to Catheter-Guided Thrombolysis in Pulmonary Thromboembolism

Last News

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Access